TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Shareholders' Equity

Annual figures by period end, from SEC filings.

$188.93M
As of 2025-12-31
+11.0%
3-year compound annual growth
+17.4%
5-year compound annual growth
2019-12-31: $59.66M2020-12-31: $84.74M2021-12-31: $107.77M2022-12-31: $138.12M2023-12-31: $146.33M2024-12-31: $158.98M2025-12-31: $188.93M$188.93M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$188.93M+18.8%2026-04-29, Balance as of period end
2024-12-31$158.98M+8.6%2026-04-29, Balance as of period end
2023-12-31$146.33M+5.9%2025-04-25, Balance as of period end
2022-12-31$138.12M+28.2%2024-04-24, Balance as of period end
2021-12-31$107.77M+27.2%2023-08-29, Balance as of period end
2020-12-31$84.74M+42.0%2022-07-29, Balance as of period end
2019-12-31$59.66Mn/a2022-07-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$188.93M+18.8%
LENSAR, Inc. (LNSR)2025-12-31-$26.02Mn/m
CVRx, Inc. (CVRX)2025-12-31$39.32M-44.7%
AVITA Medical, Inc. (RCEL)2025-12-31-$16.65Mn/m
Apyx Medical Corp (APYX)2025-12-31$14.54M+2.3%
Carlsmed, Inc. (CARL)2025-12-31$98.87Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31$63.94M-26.9%
PRO DEX Inc (PDEX)2026-06-30$47.63M+30.0%
TELA Bio, Inc. (TELA)2025-12-31$6.31M-77.8%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗